Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Early Breast Cancer Trialists' Collaborative Group
- PMID: 1345869
Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Early Breast Cancer Trialists' Collaborative Group
Comment in
-
Adjuvant treatment in breast cancer.Lancet. 1992 Feb 15;339(8790):423. Lancet. 1992. PMID: 1346673 No abstract available.
-
Adjuvant treatment in breast cancer.Lancet. 1992 Feb 15;339(8790):423-4. Lancet. 1992. PMID: 1346674 No abstract available.
Comment on
-
Adjuvant treatment in breast cancer.Lancet. 1992 Feb 15;339(8790):423. Lancet. 1992. PMID: 1346672 No abstract available.
Similar articles
-
Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Early Breast Cancer Trialists' Collaborative Group.Lancet. 1992 Jan 4;339(8784):1-15. Lancet. 1992. PMID: 1345950 Review.
-
Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.Lancet. 1998 Sep 19;352(9132):930-42. Lancet. 1998. PMID: 9752815
-
Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.Lancet. 1998 May 16;351(9114):1451-67. Lancet. 1998. PMID: 9605801
-
Randomized adjuvant trial of tamoxifen and goserelin versus cyclophosphamide, methotrexate, and fluorouracil: evidence for the superiority of treatment with endocrine blockade in premenopausal patients with hormone-responsive breast cancer--Austrian Breast and Colorectal Cancer Study Group Trial 5.J Clin Oncol. 2002 Dec 15;20(24):4621-7. doi: 10.1200/JCO.2002.09.112. J Clin Oncol. 2002. PMID: 12488405 Clinical Trial.
-
[Adjuvant therapy of breast cancer].Khirurgiia (Mosk). 2001;(5):52-60. Khirurgiia (Mosk). 2001. PMID: 11505673 Review. Russian. No abstract available.
Cited by
-
Effect of NHS breast screening programme on mortality from breast cancer in England and Wales, 1990-8: comparison of observed with predicted mortality.BMJ. 2000 Sep 16;321(7262):665-9. doi: 10.1136/bmj.321.7262.665. BMJ. 2000. PMID: 10987769 Free PMC article.
-
Organochlorine exposures influence on breast cancer risk and survival according to estrogen receptor status: a Danish cohort-nested case-control study.BMC Cancer. 2001;1:8. doi: 10.1186/1471-2407-1-8. Epub 2001 Jul 30. BMC Cancer. 2001. PMID: 11518544 Free PMC article.
-
Epidemiology and patterns of care for invasive breast carcinoma at a community hospital in Southern India.World J Surg Oncol. 2007 May 23;5:56. doi: 10.1186/1477-7819-5-56. World J Surg Oncol. 2007. PMID: 17519044 Free PMC article.
-
Breast cancer treatment in clinical practice compared to best evidence and practice guidelines.Br J Cancer. 2004 Jan 12;90(1):26-30. doi: 10.1038/sj.bjc.6601439. Br J Cancer. 2004. PMID: 14710201 Free PMC article.
-
The Riluzole Early Access Programme: descriptive analysis of 844 patients in France. ALS/Riluzole Study Group III.J Neurol. 1997 May;244 Suppl 2:S22-5. doi: 10.1007/BF03160577. J Neurol. 1997. PMID: 9178167 Clinical Trial.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical